Clinical Trials Browser

Phase 2 × Pancreatic Neoplasms × Lapatinib × Clear all

NCT00881621 2025-03-03

Lapatinib and Capecitabine for Second Line Treatment of Pancreas Cancer

Phase 2 Terminated

17 enrolled 10 charts

Gastrointestinal

Pancreatic Neoplasms

NCT00962312 2014-12-31

Lapatinib Ditosylate and Capecitabine in Treating Patients With Metastatic Pancreatic Cancer

Phase 2 Completed

Gastrointestinal

Pancreatic Neoplasms